Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

๐‰๐ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ž๐ฌ ๐‹๐จ๐ง๐๐จ๐ง: Olema Oncology more than doubled yesterday when Roche announced surprise data for its oral SERD - the CEO reacts and shares the development program for Olema's competing asset. $OLEM Full video:

BiotechTV's profile picture

BiotechTV

10,176 subscribers

12,936 Aufrufe โ€ข vor 8 Monaten โ€ขvia X (Twitter)

LIVE

Anya Rossiโ€ข Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfรผgbar

Kommentare vom Original-Post werden hier angezeigt

ร„hnliche Videos

๐‰๐ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ž๐ฌ ๐‹๐จ๐ง๐๐จ๐ง: Affinity Asset Advisors' Patrick Nosker shares a public investor's perspective on biotech and comments on a few of his firm's top positions. $XBI $XENE $MDGL $ALKS Full video:
4:30

๐‰๐ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ž๐ฌ ๐‹๐จ๐ง๐๐จ๐ง: Affinity Asset Advisors' Patrick Nosker shares a public investor's perspective on biotech and comments on a few of his firm's top positions. $XBI $XENE $MDGL $ALKS Full video:

BiotechTV

13,777 Aufrufe โ€ข vor 8 Monaten

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: AstraZeneca's CEO Pascal Soriot shares his take on M&A, oncology, Baxfendy for hypertension, the obesity market, and more. $AZN Full video:
4:58

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: AstraZeneca's CEO Pascal Soriot shares his take on M&A, oncology, Baxfendy for hypertension, the obesity market, and more. $AZN Full video:

BiotechTV

36,428 Aufrufe โ€ข vor 2 Monaten

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: After switching to a new GalNAc-LNP delivery vehicle a year ago, @VerveTx today announced the initial safety and efficacy data from its VERVE-102 PCSK9 based editor. Co-Founder & CEO Sek Kathiresan MD covers the data. $VERV Full video:
5:19

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: After switching to a new GalNAc-LNP delivery vehicle a year ago, @VerveTx today announced the initial safety and efficacy data from its VERVE-102 PCSK9 based editor. Co-Founder & CEO Sek Kathiresan MD covers the data. $VERV Full video:

BiotechTV

22,484 Aufrufe โ€ข vor 1 Jahr

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Marea Therapeutics today announced acceptance of a late-breaker at #EASCongress2025 for its ANGPTL4 inhibitor - believed to be the first ever clinical data presented for this lipid lowering target. Full video:
6:12

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Marea Therapeutics today announced acceptance of a late-breaker at #EASCongress2025 for its ANGPTL4 inhibitor - believed to be the first ever clinical data presented for this lipid lowering target. Full video:

BiotechTV

14,073 Aufrufe โ€ข vor 1 Jahr

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Abivax CEO Marc de Garidel discusses freshly released maintenance part 2 results for obefazimod in UC and describes how he believes it builds on initial data announced earlier this month. $ABVX Watch the full video:
3:01

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Abivax CEO Marc de Garidel discusses freshly released maintenance part 2 results for obefazimod in UC and describes how he believes it builds on initial data announced earlier this month. $ABVX Watch the full video:

BiotechTV

22,305 Aufrufe โ€ข vor 1 Monat

๐๐ซ๐ข๐ ๐ก๐ญ ๐Œ๐ข๐ง๐๐ฌ: William Blair Senior Biotech Analyst Andy Hsieh reacts to today's oral obesity data from Viking's VK2735 and recent data from Lilly's orforglipron. $VKTX $LLY Full video:
13:02

๐๐ซ๐ข๐ ๐ก๐ญ ๐Œ๐ข๐ง๐๐ฌ: William Blair Senior Biotech Analyst Andy Hsieh reacts to today's oral obesity data from Viking's VK2735 and recent data from Lilly's orforglipron. $VKTX $LLY Full video:

BiotechTV

68,717 Aufrufe โ€ข vor 11 Monaten

From NYSE: Gameto CEO Dina Radenkovic / Turner talks about running a women's health biotech, the development of Fertilo, work on menopause, and more. Full video:
6:09

From NYSE: Gameto CEO Dina Radenkovic / Turner talks about running a women's health biotech, the development of Fertilo, work on menopause, and more. Full video:

BiotechTV

14,405 Aufrufe โ€ข vor 1 Jahr

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib. $CRVS Full video:
4:58

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib. $CRVS Full video:

BiotechTV

24,695 Aufrufe โ€ข vor 6 Monaten

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Solid Biosciences's CEO Bo Cumbo discusses today's data release of the company's microdystrophin gene therapy candidate for Duchenne muscular dystrophy. $SLDB Full video:
7:29

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Solid Biosciences's CEO Bo Cumbo discusses today's data release of the company's microdystrophin gene therapy candidate for Duchenne muscular dystrophy. $SLDB Full video:

BiotechTV

42,139 Aufrufe โ€ข vor 1 Jahr

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Sana Bio's CEO Steve Harr describes the science behind the company's cell therapy program that aims to be a cure for type 1 diabetes. $SANA Full video:
4:40

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Sana Bio's CEO Steve Harr describes the science behind the company's cell therapy program that aims to be a cure for type 1 diabetes. $SANA Full video:

BiotechTV

19,210 Aufrufe โ€ข vor 6 Monaten

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: With three approved products and filings for more over the near term, Axsome Therapeutics's CEO describes the scale and reach this company is building in the CNS space. $AXSM Full video:
3:36

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: With three approved products and filings for more over the near term, Axsome Therapeutics's CEO describes the scale and reach this company is building in the CNS space. $AXSM Full video:

BiotechTV

20,894 Aufrufe โ€ข vor 1 Jahr

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: Metsera Inc. CEO Whit Bernard shares an update on the company's obesity programs, and comments on the state of the field post ADA. $MTSR Full video:
6:06

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: Metsera Inc. CEO Whit Bernard shares an update on the company's obesity programs, and comments on the state of the field post ADA. $MTSR Full video:

BiotechTV

10,378 Aufrufe โ€ข vor 1 Jahr

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Abivax CEO Marc de Garidel reflects on a breakout 2025 for obefazimod and key data that will read out this year. $ABVX Full video:
3:51

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Abivax CEO Marc de Garidel reflects on a breakout 2025 for obefazimod and key data that will read out this year. $ABVX Full video:

BiotechTV

73,893 Aufrufe โ€ข vor 6 Monaten

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Roche will pay Manifold Bio $55M up front, and up to $2B in milestones, to collaborate on multiple next-generation brain shuttles for neurological diseases. Full video:
4:17

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Roche will pay Manifold Bio $55M up front, and up to $2B in milestones, to collaborate on multiple next-generation brain shuttles for neurological diseases. Full video:

BiotechTV

18,780 Aufrufe โ€ข vor 9 Monaten

๐ŸšจWATCH: The push for green energy is running head first into the push for data centers. Spotsylvania County, Virginia is home to the largest solar panel development east of the Rockies. But despite its large 6,300+ acre footprint, it doesnโ€™t provide enough power for one large data center complex in Loudoun County. Loudoun County has more than 200 data centers, and Virginia has more than 600 data centers. More data centers are on the way.
2:47

๐ŸšจWATCH: The push for green energy is running head first into the push for data centers. Spotsylvania County, Virginia is home to the largest solar panel development east of the Rockies. But despite its large 6,300+ acre footprint, it doesnโ€™t provide enough power for one large data center complex in Loudoun County. Loudoun County has more than 200 data centers, and Virginia has more than 600 data centers. More data centers are on the way.

Nick Minock

164,462 Aufrufe โ€ข vor 26 Tagen

Context is the ultimate game-changer for organizations utilizing AI. In this AI-first interview, Box CEO Aaron Levie discusses the revolution weโ€™re going to see when it comes to unstructured data and its value for AI. Watch the full video:
2:33

Context is the ultimate game-changer for organizations utilizing AI. In this AI-first interview, Box CEO Aaron Levie discusses the revolution weโ€™re going to see when it comes to unstructured data and its value for AI. Watch the full video:

Box

1,107,792 Aufrufe โ€ข vor 1 Jahr

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: BridgeBio Pharma Founder & CEO Neil Kumar and Roivant Sciences CEO Matt Gline discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term. $BBIO $ROIV Watch the full episode:
6:11

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: BridgeBio Pharma Founder & CEO Neil Kumar and Roivant Sciences CEO Matt Gline discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term. $BBIO $ROIV Watch the full episode:

BiotechTV

11,639 Aufrufe โ€ข vor 3 Monaten

The Government has announced the details of its infrastructure plans for the next five years. The revised National Development Plan includes โ‚ฌ112bn funding for housing, energy, water and transport projects | Read more:
0:36

The Government has announced the details of its infrastructure plans for the next five years. The revised National Development Plan includes โ‚ฌ112bn funding for housing, energy, water and transport projects | Read more:

RTร‰ News

17,012 Aufrufe โ€ข vor 1 Jahr

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐“๐ฎ๐ž๐ฌ๐๐š๐ฒ๐ฌ: Mizuho Americas Senior Analyst Graig Suvannavejh shares his take on the difficult biotech environment and discusses upcoming clinical trail catalysts for companies he covers. $AXSM $VIGL $VSTM $CRVS $HRMY Full video:
6:08

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐“๐ฎ๐ž๐ฌ๐๐š๐ฒ๐ฌ: Mizuho Americas Senior Analyst Graig Suvannavejh shares his take on the difficult biotech environment and discusses upcoming clinical trail catalysts for companies he covers. $AXSM $VIGL $VSTM $CRVS $HRMY Full video:

BiotechTV

13,455 Aufrufe โ€ข vor 1 Jahr